SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ZILA--test for oral cancer?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Grainne who wrote (3)5/23/1996 10:37:00 PM
From: Julio P. Antelo   of 61
 
ZILA - new thread.

We seemed to have abandoned the old thread and picked up a new one here. Two points about investing in Zila: 1. definitely a long term investment. Although you will probably see a quick run up when FDA approval is granted and/or a new marketing partner is announced, the true potential of this company lies in the marketing of their toulidine blue compound as you well pointed out in your post. Zila's future at this point is inexorably linked to this product and, in my estimation, they are doing a fine job of safeguarding their investment. 2. In late March-early April P&G gave the company notice of their intent to break off their partnership. P&G had to give Zila 90 days notice, and this time frame will not expire until late June-early July. Although I hope I'm wrong, I personally do not expect Zila to announce any deals until this legal requirement is out of the way.

I have been in this stock since 1989 and plan to own it many more years. Good luck to you. Julio
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext